Bronte Capital Management Pty Ltd. - Q3 2021 holdings

$1.37 Billion is the total value of Bronte Capital Management Pty Ltd.'s 27 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.

 Value Shares↓ Weighting
GOOGL  ALPHABET INCcap stk cl a$131,473,000
+9.5%
49,1760.0%9.62%
+12.3%
V  VISA INC$39,525,000
-4.7%
177,4400.0%2.89%
-2.2%
BK  BANK NEW YORK MELLON CORP$25,811,000
+1.2%
497,8910.0%1.89%
+3.8%
STT  STATE STR CORP$22,754,000
+3.0%
268,5740.0%1.66%
+5.6%
GOOG  ALPHABET INCcap stk cl c$18,583,000
+6.3%
6,9720.0%1.36%
+9.1%
MO  ALTRIA GROUP INC$13,090,000
-4.5%
287,5610.0%0.96%
-2.0%
BYND  BEYOND MEAT INCput$10,526,000
-33.2%
100,0000.0%0.77%
-31.4%
MACK  MERRIMACK PHARMACEUTICALS IN$2,651,000
-24.4%
548,8360.0%0.19%
-22.4%
DBTX  DECIBEL THERAPEUTICS INC$1,229,000
-10.4%
159,4620.0%0.09%
-8.2%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-09
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BERKSHIRE HATHAWAY INC DEL20Q3 202322.6%
ALPHABET INC-CL A20Q3 202314.4%
HERBALIFE NUTRITION LTD20Q3 202322.0%
INTERACTIVE BROKERS GROUP20Q3 202312.4%
ALPHABET INC-CL C20Q3 20235.7%
VISA INC-CLASS A SHARES19Q2 202316.6%
CORTEVA NC17Q3 20236.2%
GRAHAM HOLDINGS CO-CLASS B13Q3 20232.1%
REGENERON PHARMACEUTICALS12Q3 202313.0%
STATE STREET CORP12Q2 20233.0%

View Bronte Capital Management Pty Ltd.'s complete holdings history.

Latest filings
TypeFiled
SCHEDULE 13G2024-02-13
13F-HR2024-02-07
13F-HR2023-11-06
13F-HR2023-08-08
13F-HR2023-05-12
13F-HR2023-02-14
13F-HR2022-11-03
13F-HR/A2022-08-08
13F-HR2022-08-08
13F-HR2022-05-13

View Bronte Capital Management Pty Ltd.'s complete filings history.

Compare quarters

Export Bronte Capital Management Pty Ltd.'s holdings